Nurix Historical Financial Ratios
| NRIX Stock | USD 13.51 0.44 3.15% |
Nurix TherapeuticsInc is lately reporting on over 95 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Days Sales Outstanding of 4.14 will help investors to properly organize and evaluate Nurix TherapeuticsInc financial condition quickly.
Nurix |
About Nurix Financial Ratios Analysis
Nurix TherapeuticsIncFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Nurix TherapeuticsInc investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Nurix financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Nurix TherapeuticsInc history.
Nurix TherapeuticsInc Financial Ratios Chart
Nurix TherapeuticsInc financial ratios usually calculated using numerical values taken directly from Nurix TherapeuticsInc financial statements such as income statements or balance sheets. They help investors to obtain meaningful information about Nurix TherapeuticsInc. Most financial ratios help to conduct quantitative analysis to assess vital information about the company's valuation as well as profitability and liquidity indicators such as leverage, growth, profit margins, and different types of rates of return.
At this time, Nurix TherapeuticsInc's Shareholders Equity Per Share is fairly stable compared to the past year. Graham Net Net is likely to rise to 2.34 in 2024, whereas Price To Sales Ratio is likely to drop 4.80 in 2024. Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Nurix TherapeuticsInc stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Nurix TherapeuticsInc sales, a figure that is much harder to manipulate than other Nurix TherapeuticsInc multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company’s stock price to its revenues, calculated by dividing the company’s market cap by its total sales or revenue over a 12-month period.Ev To Sales
The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.Payables Turnover
A liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable.Most ratios from Nurix TherapeuticsInc's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Nurix TherapeuticsInc current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nurix TherapeuticsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy Nurix Stock please use our How to Invest in Nurix TherapeuticsInc guide.At this time, Nurix TherapeuticsInc's Shareholders Equity Per Share is fairly stable compared to the past year. Graham Net Net is likely to rise to 2.34 in 2024, whereas Price To Sales Ratio is likely to drop 4.80 in 2024.
| 2021 | 2022 | 2023 (projected) | Current Ratio | 4.51 | 3.4 | 3.06 | Net Debt To EBITDA | 0.29 | 0.17 | 0.2 |
Nurix TherapeuticsInc fundamentals Correlations
Click cells to compare fundamentals
Nurix TherapeuticsInc Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Nurix TherapeuticsInc fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Price To Sales Ratio | 37.49 | 41.55 | 15.59 | 4.39 | 5.05 | 4.8 | |
| Ptb Ratio | 2.3 | 3.61 | 1.98 | 1.69 | 1.52 | 1.59 | |
| Book Value Per Share | 18.52 | 7.98 | 6.25 | 3.69 | 3.32 | 4.35 | |
| Free Cash Flow Yield | (0.001422) | (0.006936) | (0.0728) | (0.29) | (0.27) | (0.31) | |
| Invested Capital | (0.08) | 0.0263 | 0.0381 | 0.0394 | 0.15 | 0.14 | |
| Stock Based Compensation To Revenue | 0.24 | 0.53 | 0.73 | 0.44 | 0.39 | 0.31 | |
| Capex To Depreciation | (2.09) | (0.93) | (1.13) | (0.62) | (0.71) | (0.74) | |
| Pb Ratio | 2.3 | 3.61 | 1.98 | 1.69 | 1.52 | 1.59 | |
| Ev To Sales | 30.79 | 39.29 | 14.23 | 4.08 | 4.69 | 4.46 | |
| Free Cash Flow Per Share | (0.3) | (2.1) | (3.54) | (1.65) | (1.9) | (1.99) | |
| Roic | (0.15) | (0.33) | (0.54) | (0.67) | (0.77) | (0.73) | |
| Net Income Per Share | (2.76) | (2.73) | (3.42) | (2.65) | (3.05) | (3.2) | |
| Sales General And Administrative To Revenue | 0.92 | 1.05 | 0.98 | 0.56 | 0.5 | 0.53 | |
| Research And Ddevelopement To Revenue | 3.73 | 3.91 | 4.78 | 2.36 | 2.12 | 2.3 | |
| Capex To Revenue | (0.0531) | (0.26) | (0.19) | (0.32) | (0.11) | (0.13) | |
| Cash Per Share | 17.94 | 6.89 | 6.36 | 5.3 | 4.77 | 5.32 | |
| Pocfratio | (8.4K) | (14.65) | (3.77) | (4.15) | (3.74) | (3.93) | |
| Capex To Operating Cash Flow | 56.91 | 0.0671 | 0.0766 | 0.1 | 0.12 | 0.11 | |
| Pfcf Ratio | (144.18) | (13.73) | (3.5) | (3.77) | (3.39) | (3.56) | |
| Days Payables Outstanding | 18.73 | 399.09 | 171.02 | 171.11 | 154.0 | 123.66 | |
| Income Quality | 0.00185 | 0.72 | 0.89 | 0.57 | 0.65 | 1.01 | |
| Roe | (0.15) | (0.34) | (0.55) | (0.72) | (0.83) | (0.78) | |
| Ev To Operating Cash Flow | (6.9K) | (13.85) | (3.44) | (3.86) | (3.47) | (3.65) | |
| Pe Ratio | (15.45) | (10.55) | (3.63) | (2.35) | (2.11) | (2.22) | |
| Return On Tangible Assets | (0.11) | (0.24) | (0.4) | (0.39) | (0.45) | (0.48) | |
| Ev To Free Cash Flow | (118.42) | (12.98) | (3.2) | (3.5) | (3.15) | (3.31) | |
| Earnings Yield | (0.0647) | (0.0948) | (0.28) | (0.43) | (0.49) | (0.47) | |
| Net Debt To E B I T D A | 1.84 | 0.57 | 0.29 | 0.17 | 0.2 | 0.19 | |
| Current Ratio | 2.44 | 6.7 | 4.7 | 4.51 | 3.4 | 3.06 | |
| Tangible Book Value Per Share | 18.52 | 7.98 | 6.25 | 3.69 | 3.32 | 4.35 | |
| Graham Number | 33.91 | 22.15 | 21.91 | 14.83 | 13.35 | 13.68 | |
| Shareholders Equity Per Share | 18.52 | 7.98 | 6.25 | 3.69 | 3.32 | 4.35 | |
| Debt To Equity | (0.08) | 0.0263 | 0.0381 | 0.0394 | 0.15 | 0.14 | |
| Capex Per Share | (0.29) | (0.13) | (0.25) | (0.15) | (0.18) | (0.19) | |
| Graham Net Net | 11.71 | 3.87 | 4.04 | 2.29 | 2.06 | 2.34 | |
| Revenue Per Share | 1.14 | 0.69 | 0.79 | 1.42 | 1.63 | 1.31 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Nurix TherapeuticsInc in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Nurix TherapeuticsInc's short interest history, or implied volatility extrapolated from Nurix TherapeuticsInc options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nurix TherapeuticsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy Nurix Stock please use our How to Invest in Nurix TherapeuticsInc guide.You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Complementary Tools for Nurix Stock analysis
When running Nurix TherapeuticsInc's price analysis, check to measure Nurix TherapeuticsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nurix TherapeuticsInc is operating at the current time. Most of Nurix TherapeuticsInc's value examination focuses on studying past and present price action to predict the probability of Nurix TherapeuticsInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nurix TherapeuticsInc's price. Additionally, you may evaluate how the addition of Nurix TherapeuticsInc to your portfolios can decrease your overall portfolio volatility.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Stocks Directory Find actively traded stocks across global markets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |
Is Nurix TherapeuticsInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nurix TherapeuticsInc. If investors know Nurix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nurix TherapeuticsInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.66) | Revenue Per Share 1.483 | Quarterly Revenue Growth 0.307 | Return On Assets (0.29) | Return On Equity (0.65) |
The market value of Nurix TherapeuticsInc is measured differently than its book value, which is the value of Nurix that is recorded on the company's balance sheet. Investors also form their own opinion of Nurix TherapeuticsInc's value that differs from its market value or its book value, called intrinsic value, which is Nurix TherapeuticsInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nurix TherapeuticsInc's market value can be influenced by many factors that don't directly affect Nurix TherapeuticsInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nurix TherapeuticsInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nurix TherapeuticsInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nurix TherapeuticsInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.